L851-1430 Screening compound: 3-(2-fluorophenyl)-5-[1-methyl-5-(2-methylbenzoyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]-1,2,4-oxadiazole

L851-1430 Screening compound: 3-(2-fluorophenyl)-5-[1-methyl-5-(2-methylbenzoyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]-1,2,4-oxadiazole
L851-1430 Screening compound: 3-(2-fluorophenyl)-5-[1-methyl-5-(2-methylbenzoyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]-1,2,4-oxadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L851-1430
3-(2-fluorophenyl)-5-[1-methyl-5-(2-methylbenzoyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]-1,2,4-oxadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L851-1430

Molecular Formula

C23H20FN5O2 (C23 H20 FN5 O2)

Compound Name

3-(2-fluorophenyl)-5-[1-methyl-5-(2-methylbenzoyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]-1,2,4-oxadiazole

IUPAC name

3-(2-fluorophenyl)-5-[1-methyl-5-(2-methylbenzoyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl]-124-oxadiazole

SMILES

Cc(cccc1)c1C(N(CC1)Cc2c1n(C)nc2-c1nc(-c(cccc2)c2F)no1)=O

InChI

InChI=1S/C23H20FN5O2/c1-14-7-3-4-8-15(14)23(30)29-12-11-19-17(13-29)20(26-28(19)2)22-25-21(27-31-22)16-9-5-6-10-18(16)24/h3-10H,11-13H2,1-2H3

InChI Key

VLDFHGCFGBWUNU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28120044

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.197

Distribution Coefficient, logD

3.197

Water Solubility, LogSw

-3.41

Polar Surface Area

62.972

Acid Dissociation Constant (pKa)

21.25

Base Dissociation Constant (pKb)

-0.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

L851-1430 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L851-1430 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L851-1430?
Check Price and Availability of L851-1430, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L851-1430 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L851-1430
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L851-1430
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L851-1430 available by request